Spectroscopic and quantum chemical characterization of 4-[2-(2-Amino-4,7-dihydro-4-oxo-3 H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid with molecular docking and cytotoxicity insights for targeting NSCLC
In Silico Pharmacology · 01.04.2026 · 14 (1)
DOI: 10.1007/s40203-026-00616-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 01.04.2026. Verfasst von Meenakumari Vijayaraghavan und 4 weiteren Autor:innen. Beteiligte Einrichtung: P.G. and Research Department of Physics, Nadar Mahajana Sangam S. Vellaichamy Nadar College, Nagamalai, Madurai, Tamil Nadu 625019 India. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- P.G. and Research Department of Physics, Nadar Mahajana Sangam S. Vellaichamy Nadar College, Nagamalai, Madurai, Tamil Nadu 625019 India.
Zitieren
APA
Vijayaraghavan, M., Petchimuthu, R., Rajendran, P., Jeganathan, M., & Amirtham, M. F. B. (2026). Spectroscopic and quantum chemical characterization of 4-[2-(2-Amino-4,7-dihydro-4-oxo-3 H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid with molecular docking and cytotoxicity insights for targeting NSCLC. In Silico Pharmacology, 14(1). https://doi.org/10.1007/s40203-026-00616-5
Vancouver
Vijayaraghavan M, Petchimuthu R, Rajendran P, Jeganathan M, Amirtham MFB. Spectroscopic and quantum chemical characterization of 4-[2-(2-Amino-4,7-dihydro-4-oxo-3 H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid with molecular docking and cytotoxicity insights for targeting NSCLC. In Silico Pharmacology. 2026;14(1). doi:10.1007/s40203-026-00616-5
BibTeX
@article{Vijayaraghavan2026,
author = {Vijayaraghavan, Meenakumari and Petchimuthu, Rooban and Rajendran, Premkumar and Jeganathan, Mangaiyarkkarasi and Amirtham, Milton Franklin Benial},
title = {Spectroscopic and quantum chemical characterization of 4-[2-(2-Amino-4,7-dihydro-4-oxo-3 H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid with molecular docking and cytotoxicity insights for targeting NSCLC},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40203-026-00616-5}
}
EUVIMED